Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03007017 · ClinicalTrials.gov registry record · NA
Novel Strategies for Innovating Deceased Donor Procurement
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03007017 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 2 participants.
The verdict
NCT03007017, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Despite many efforts to increase the size of the donor pool, there is a large and growing disparity between the number of donor kidneys available for transplantation and the number of patients on the transplant waiting list. Increasing the quality of currently available donor kidneys would potentially improve the longevity of deceased donor kidney transplants by years, thus increasing the rate of transplantation patients on the kidney transplant waiting list. In addition, recipients of higher quality kidneys have shorter hospital stays and lower total hospital charges. By innovating the organ donation process, such that deceased donor kidneys are removed prior to the cessation of cardiac activity, rather than after, it may be possible to improve the quality of the kidney before transplantation, resulting in improved function after transplantation and increased longevity of these transplanted kidneys. Further, this improved kidney quality is highly likely to translate to reduced need for renal dialysis and other high-cost interventions, yielding lower total hospital charges. In this study we will test the hypothesis that, through a cost-free technical innovation, the quality of deceased donor kidneys could be improved significantly, saving thousands more lives per year and reducing total health care expenditures on renal transplantation.
Interventions
- PROCEDURE Deceased donor nephrectomy, prior to cross clamp of donor aorta
- PROCEDURE Deceased donor nephrectomy, standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-01 |
| Est. Completion | 2021-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03007017
The ClinicalTrials.gov registry entry for NCT03007017 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Deceased donor nephrectomy, prior to cross clamp of donor aorta is the first listed.
NCT03007017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03007017 about?
NCT03007017 is a clinical study titled "Novel Strategies for Innovating Deceased Donor Procurement". Despite many efforts to increase the size of the donor pool, there is a large and growing disparity between the number of donor kidneys available for transplantation and the number of patients on the transplant waiting list. Increasing the quality of currently available donor kidneys would potential...
What is the current status of trial NCT03007017?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2017-01. Estimated completion is 2021-06-07.
What interventions are being tested in trial NCT03007017?
The interventions under investigation include: Deceased donor nephrectomy, prior to cross clamp of donor aorta (PROCEDURE), Deceased donor nephrectomy, standard of care (PROCEDURE).
Who is sponsoring clinical trial NCT03007017?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.